Glaxosmithkline | GSK - Operating Profit

Stock Price
59.20
Daily Change
10.91 22.59%
Monthly
21.54%
Yearly
62.73%
Q1 Forecast
50.58

Glaxosmithkline reported GBP3.76B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bausch Health Companies USD 717M 260M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Glaxosmithkline GBP 3.76B 1.32B Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025
Takeda JPY 168.82B 479.89B Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
Zoetis USD 936M 63M Sep/2025